Underwriting idiopathic interstitial lung diseases

Interstitial lung disease (ILD) incorporates a large number of pathologic processes that have in the interstitial compartment of the lung. This article focuses on the diagnosis, morbidity and mortality implications of persons diagnosed with idiopathic interstitial pneumonias/fibrosis. Even within this category, the mortality and morbidity varies greatly (from months to near-normal mortality) given the specific disease present.